Naiba Nabieva

Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry

Volkmar Müller, Naiba Nabieva, Lothar Häberle et al. · The Breast · 2017 · 68 citations

Medicine, Health Sciences, Oncology +17

Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors – Data from the German PRAEGNANT breast cancer registry

Andreas D. Hartkopf, Jens Huober, Bernhard Volz et al. · The Breast · 2017 · 61 citations

Medicine, Endocrinology, Oncology +15

Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany

Andreas Schneeweiß, Johannes Ettl, Diana Lüftner et al. · The Breast · 2020 · 58 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis

Peter A. Fasching, Andreas D. Hartkopf, Lothar Häberle et al. · Breast Cancer Research and Treatment · 2018 · 51 citations

Medicine, Oncology, Pharmacology +14

Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study

Naiba Nabieva, Tanja Fehm, Lothar Häberle et al. · European Journal of Cancer · 2018 · 49 citations

Medicine, Oncology, Pharmacology +17